Oculis Holding AG announced that Privosegtor, in its Phase 2 ACUITY trial, significantly reduced increases in plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) compared to placebo in patients with optic neuritis. These biomarkers indicate reduced neuroaxonal injury and inflammation, supporting earlier findings of improved visual function and retinal preservation. The data reinforce Privosegtor's potential as a neuroprotective therapy for optic neuritis and acute multiple sclerosis relapses, with ongoing plans for further clinical development and regulatory submissions.
Oculis Holding AG's Privosegtor trial data is the subject, with Pluang market data providing context. For readers following Health-sector US stocks, here is Pluang's market snapshot as of Oct 22, 2026 12:11 WIB: Out of 150 priced stocks, 70 rose and 79 fell. Notable movers include AVTR at USD 17.40 (+4.69%), NVAX at USD 10.90 (-4.64%) with 99% sell order activity, and ROIV at USD 36.52 (+4.58%) with 100% buy order activity. Typical hold times range from 6 to 59 days.
Oculis Holding AG announced that Privosegtor, in a Phase 2 ACUITY trial, reduced increases in blood biomarkers linked to nerve damage (NfL and GFAP) in patients with optic neuritis compared to placebo. These biomarker improvements support earlier fin...
Ipsen reported a 24.6% sales growth at constant exchange rates for the first nine months of 2026, driven by strong performance in Oncology, Rare Disease, and Neuroscience segments. The company upgraded its full-year sales growth guidance to around 23...
Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, a key infrastructure initiative aimed at strengthening the electricity network's security and resilience in the Balearic Islands. ...
Roche reported a 7% sales increase at constant exchange rates in Q3 2026, with a 6% rise for the first nine months, fueled by high demand for key medicines like Xolair, Hemlibra, and Ocrevus. The Pharmaceuticals Division led growth, while Diagnostics...
Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, aimed at enhancing the electricity network's security and resilience in the Balearic Islands. The project includes a six-month eng...
